Related Experiment Video
Updated: Aug 3, 2026
09:58
Light-driven Enzymatic Decarboxylation
Published on: May 22, 2016
Cytochrome P450 monooxygenases: perspectives for synthetic application
Vlada B Urlacher1, Sabine Eiben
1Institute of Technical Biochemistry, University of Stuttgart, Allmandring 31, D-70569 Stuttgart, Germany. itbvur@itb.uni-stuttgart.de
Trends in Biotechnology
|June 9, 2006
Summary
Cytochrome P450 monooxygenases are powerful biocatalysts for chemical synthesis. Protein engineering and cofactor regeneration strategies are enhancing their industrial applications and overcoming limitations for broader commercial use.
Area of Science:
- Biochemistry
- Biocatalysis
- Enzyme Engineering
Background:
- Cytochrome P450 monooxygenases are versatile enzymes catalyzing oxygen incorporation into diverse molecules.
- Their regio- and stereoselective reactions are valuable in drug development, bioremediation, and fine chemical synthesis.
- Current limitations hinder the full commercial exploitation of P450 monooxygenases.
Purpose of the Study:
- To review advancements in P450 enzyme optimization for synthetic applications.
- To highlight strategies addressing commercial implementation challenges.
- To focus on protein engineering and cofactor regeneration for P450s.
Main Methods:
- Protein engineering to modify substrate specificity, activity, and stability.
- Development of electrochemical and enzymatic methods for NAD(P)H regeneration.
- Review of literature on P450 applications and optimization.
Main Results:
- Engineered P450s exhibit altered substrate specificities, enhanced activity, and improved stability.
- Cofactor regeneration systems enable more cost-effective P450 enzyme utilization.
- Optimized P450s show increased potential for industrial synthetic processes.
Conclusions:
- Protein engineering and cofactor regeneration are key to unlocking the commercial potential of P450 monooxygenases.
- These advancements facilitate broader applications in chemical synthesis and biotechnology.
- Further optimization will drive wider adoption of P450 biocatalysts.
More Related Videos
![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
Related Concept Videos
02:44Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
01:24Peroxisomes
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
01:17Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
01:19Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
01:15Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems
Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...